Anesthesia: Malignant Hyperthermia Response
Malignant hyperthermia is a rare, inherited (genetic) disorder that is potentially fatal. It can be triggered by exposure to certain
The disorder is caused by too-rapid
When triggered by
Malignant hyperthermia is very rare. But you may be at an increased chance of getting it if:
You can have a test to help find out if you have an increased chance of malignant hyperthermia.
People at risk of malignant hyperthermia may have a
Treatment for malignant hyperthermia includes discontinuing the anesthesia immediately, giving the person 100% oxygen to breathe, and administering the medicine dantrolene. The person usually needs to continue receiving dantrolene for 12 to 48 hours and needs to be closely watched in an intensive care unit.
If a person who is at possible risk of malignant hyperthermia needs anesthesia, the condition can be safely and completely avoided by choosing anesthetic agents that do not trigger malignant hyperthermia.
You can get more information about malignant hyperthermia from the Malignant Hyperthermia Association of the United States (MHAUS). Go to the website at www.mhaus.org.
eMedicineHealth Medical Reference from Healthwise
To learn more visit Healthwise.org
© 1995-2014 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.